Loading...

Clene Inc.

CLNNW•NASDAQ
Healthcare
Biotechnology
$0.04
$0.005(17.36%)

Clene Inc. (CLNNW) Stock Overview

Explore Clene Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 66.7/100

Key Financials

Market Cap32.7M
P/E Ratio-1.12
EPS (TTM)N/A
ROE6.30%
Fundamental Analysis

AI Price Forecasts

1 Week$0.03
1 Month$0.00
3 Months$0.03
1 Year Target$0.04

CLNNW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Clene Inc. (CLNNW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.71, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.04.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.12 and a market capitalization of 32.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;